|
|
||||
|
NIH Proposes a One-Year Ban on Consulting
Potential conflicts of interest prompt the move; some say patients could suffer
The Scientist 2004, 18(21):37
|
||||
|
|
||||
|
A proposed ban on consulting at the National Institutes of Health might make it more difficult to translate basic research findings into new drugs and therapies, according to pharmaceutical and biotech companies, who say they will need to tap new sources to provide expert help in ongoing research. The NIH announced in September that it would seek to ban its scientists from all outside paid consulting activities with drug and biotech companies for at least one year, while the agency reviews its procedures and develops more effective oversight systems.
|
|
|||||||||
|
|||||||||
|